The global race for patents in the healthcare and medical technology sectors is intensifying, with China rapidly emerging as a dominant force. A new report from the China Intellectual Property Publishing House reveals a significant shift in the landscape of innovation, with Chinese entities now holding over half of all medical and health-related patents worldwide. This surge in intellectual property activity underscores China’s growing ambition and investment in becoming a global leader in healthcare innovation, a trend with far-reaching implications for the future of medicine and public health.
The report, titled “2025 Medical & Health Industry Patent Analysis White Paper,” provides a comprehensive overview of patent filing trends and competitive dynamics within the global medical and health industry. Released on March 3, 2026, the white paper analyzes patent application data up to November 30, 2025, revealing a cumulative total of over 470,000 patents filed globally between 2019 and 2025. While patent filings experienced consistent growth from 2019 to 2023, a slight decline has been observed since 2024, potentially reflecting broader economic shifts or changes in research and development priorities.
China’s Ascendancy in Healthcare Patents
Geographically, patent filings are concentrated in China, the United States, South Korea, India, Japan, and the European Patent Office (EPO). Though, it is China’s growth rate that stands out. Fueled by substantial investments in healthcare infrastructure, a rapidly expanding digital technology sector, and a growing emphasis on integrating artificial intelligence with medical practices, China has experienced an average annual growth rate of approximately 15.7% in patent filings since 2019. This rapid expansion has propelled China to the forefront of global healthcare innovation.
Currently, China holds over 249,000 medical and health industry patents, representing 52.4% of the global total – the largest share of any nation. According to the Korea Institute of Intellectual Property and Technology Advancement (KIPIT), this dominance reflects China’s strategic focus on building a robust healthcare ecosystem and leveraging its vast data resources.
Top Patent Holders: A Shifting Landscape
The ranking of global patent holders further illustrates the growing influence of Chinese companies and institutions. The top 10 patent holders in the medical and health industry now include a significant number of Chinese entities. Leading the pack is Ping An Group, a Chinese conglomerate, with a portfolio of 5,704 patents. This marks the first time a Chinese company has topped the global rankings, signaling a significant power shift in healthcare innovation.
Following Ping An, Dutch multinational Philips holds the second position with 5,258 patents, while German engineering giant Siemens ranks third with 3,133 patents. Japanese companies also maintain a strong presence, with Canon (2,915 patents) at number four, NEC (2,114 patents) at number five, and Fujifilm (1,788 patents) at number nine. Notably, South Korean conglomerate Samsung Group has secured a place among the top contenders, ranking sixth with 2,085 patents, demonstrating its commitment to innovation in the medical technology space.
Other prominent Chinese companies featured in the top 10 include Tencent Group (1,901 patents) at number seven and Zhejiang University (1,838 patents) at number eight. Rounding out the list is American technology company IBM, holding 1,518 patents at number ten. This concentration of Chinese entities within the top 10 underscores the nation’s increasing prominence in driving innovation within the healthcare sector.
Digital Health and the Future of Patent Competition
Experts predict that the competition for patents in the medical and health industry will continue to intensify, driven by the rapid expansion of digital technologies, artificial intelligence, and data-driven services. The convergence of medical technology and information technology, particularly in the field of digital healthcare, is expected to be a key area of focus for patent activity. KIPIT’s analysis suggests that patent competition in this domain will serve as a crucial indicator of technological competitiveness.
The rise of digital health also presents new challenges and opportunities for intellectual property protection. As healthcare becomes increasingly reliant on data and algorithms, ensuring the security and privacy of patient information will be paramount. The development of interoperable systems and standards will be essential to facilitate the seamless exchange of data and promote innovation. The ability to secure patents for innovative digital health solutions will be critical for companies seeking to gain a competitive edge in this rapidly evolving market.
Implications for Global Healthcare
China’s growing dominance in healthcare patents has significant implications for the global healthcare landscape. Increased competition among innovators could lead to faster development of new technologies and treatments, ultimately benefiting patients worldwide. However, it also raises concerns about intellectual property rights and the potential for unfair competition.
The concentration of patents in the hands of a few key players could also limit access to essential technologies, particularly in developing countries. Addressing these challenges will require international cooperation and the development of policies that promote innovation while ensuring equitable access to healthcare solutions. The increasing reliance on data-driven technologies raises ethical considerations regarding data privacy, algorithmic bias, and the responsible use of artificial intelligence in healthcare.
The trend also highlights the importance of continued investment in research and development, both in China and in other countries. Maintaining a competitive edge in healthcare innovation will require sustained funding for basic research, translational research, and the development of new technologies. Collaboration between academia, industry, and government will be essential to accelerate the pace of innovation and address the pressing healthcare challenges facing the world today.
The evolving patent landscape in the medical and health industry underscores the critical role of intellectual property in driving innovation and shaping the future of healthcare. As China continues to assert its dominance in this field, it will be crucial for policymakers, researchers, and industry leaders to adapt to the changing dynamics and ensure that innovation benefits all of humanity.
Looking ahead, the next key development to watch will be the release of updated patent data for the first half of 2026, expected in late 2026. This will provide a more comprehensive picture of the evolving trends in healthcare innovation and the continued rise of China as a global leader in this critical sector. We encourage readers to share their thoughts and perspectives on this essential topic in the comments below.
Related reading